Overview of Dr. Rostomily
Dr. Robert Rostomily is a neurosurgeon in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 30 years. Dr. Rostomily accepts several types of health insurance, listed below. He is one of 48 doctors at Houston Methodist Hospital who specialize in Neurosurgery. He has more than 90 publications and over 500 citings.
Office
6560 Fannin St
Ste 900
Houston, TX 77030Fax+1 713-793-1015
Education & Training
- University of WashingtonResidency, Neurological Surgery, 1987 - 1995
- Case Western Reserve University School of MedicineClass of 1987
Certifications & Licensure
- TX State Medical License 2016 - 2025
- WA State Medical License 1989 - 2022
- DC State Medical License 1998 - 2000
- WI State Medical License 1999 - 1999
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Fellow (FAANS) American Association of Neurological Surgeons
Publications & Presentations
PubMed
- Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST1.Srijana Upadhyay, Miok Lee, Lei Zhang, Arafat Rahman Oany, Svetlana A Mikheeva
Molecular Pharmacology. 2025-02-01 - 1 citationsAnalysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.Karol Bomsztyk, Daniel Mar, Oleg Denisenko, Suzanne Powell, Monika Vishnoi
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024-12-01 - Hemin-Induced Transient Senescence Via DNA Damage Response: A Neuroprotective Mechanism Against Ferroptosis in Intracerebral Hemorrhage.Vikas H Maloji Rao, Velmarini Vasquez, Manohar Kodavati, Joy Mitra, Vincent Provasek
Research Square. 2024-07-26
Press Mentions
- UTEP Gets Portion of $142M Grant from Cancer Prevention & Research Institute of TexasAugust 19th, 2021
- Neurology Questions? Ask the Experts at Houston Methodist Q&A SessionOctober 16th, 2018
Grant Support
- “Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”METHODIST HOSPITAL RESEARCH INSTITUTE2023–2028
- “Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”METHODIST HOSPITAL RESEARCH INSTITUTE2023–2028
- “Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”METHODIST HOSPITAL RESEARCH INSTITUTE2023–2028
- A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle stateMETHODIST HOSPITAL RESEARCH INSTITUTE2024–2027
- Development of a pre-clinical syngeneic pig glioma model for research and translational studiesMETHODIST HOSPITAL RESEARCH INSTITUTE2024–2026
- Development of a pre-clinical syngeneic pig glioma model for research and translational studiesMETHODIST HOSPITAL RESEARCH INSTITUTE2024–2026
- Development of a pre-clinical syngeneic pig glioma model for research and translational studiesMETHODIST HOSPITAL RESEARCH INSTITUTE2024–2026
- Patterned optogenetic neuromodulation to reprogram glioma stem cellsMETHODIST HOSPITAL RESEARCH INSTITUTE2024–2025
- Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker AssayUNIVERSITY OF WASHINGTON2020–2025
- Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker AssayUNIVERSITY OF WASHINGTON2020–2025
- Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker AssayUNIVERSITY OF WASHINGTON2020–2025
- Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker AssayUNIVERSITY OF WASHINGTON2020–2025
- TWIST1 As A Target For Inhibition Of Glioma InvasionNational Cancer Institute2011–2012
- Modeling Gliomagenesis With Aging Glial Progenitor Cells And HostsNational Institute On Aging2007–2009
- The Role Of Bhlh Genes In Gliogenesis And Glioma BiologyNational Institute Of Neurological Disorders And Stroke2000–2004
- Migration Of Astrocytes In CNS White MatterNational Institute Of Neurological Disorders And Stroke1993–1996
Professional Memberships
- Fellow
- Member
Insurance Accepted
- Aetna Choice POS II
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
Capital BC Keystone Health Plan Central HMO
Capital Blue Cross PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
Great West PPO
Health Net Oregon PPOHealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PHCS PPO
Multiplan PPO
Premera BCBS Heritage & Heritage Plus 1
Providence Health System Personal Option
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: